Name：Evaluation & analysis of medicinal in Chinese
Supervisory unit：China Medical Biotechnology Association
Organizer：China Medical Biotechnology Association & Chongqing University Cancer Hospital
Chairman of the Editorial Board：Du Guanhua
Chairman：Wu Yongzhong
Editor in Chief：Zhang Xianglin
Executive editor：Luo Rui
Publication：China Medicine Biotechnology Press Co., Ltd.
Cycle：Monthly
Address：Beijing
Language：Chinese
Size：16mo
Current Journal
Scan QR code to subscribe
Scan QR code to subscribe
About the Journal
-
Progress on Application of Ceftobiprole Medocaril Sodium in the Treatment of Blood Stream Infection Induced by Methicillin Resistant Staphylococcus aureus
New
Author：LÜ Peng、 ZHANG Qian、 HUANG Yifei、 ZHANG Zhuo2026-3 -
Master of Traditional Chinese Medicine Jin Shiyuan’s Brief Analysis on Five Major Functions, Indications, and Rational Use of Niuhuang-Containing Chinese Patent Medicines
New
Author：LIU Chunyu、 LIU Shuo、 ZHANG Nan、 ZHAO Kuijun、 ZHAI Huaqiang、 JIN Shiyuan2026-3
-
Review of 2 400 Outpatient Prescriptions for Cardiovascular Disease and Pareto Analysis of Irrational Prescriptions
New
Author：ZHU Yiming、 WU Jinxia、 SU Zhiheng2026-3
-
Mining and Analysis of Adverse Drug Events Signals Related to Teprotumumab Based on the U. S. FAERS Database
New
Author：XU Jingzhou、 ZHANG Xu2026-3
-
Characteristic and Rationality of 49 685 Prescriptions for Class Ⅱ Psychotropic Drugs
New
Author：ZENG Qiuming、 LI Fangyuan、 LIU Huanhuan、 LIANG Qi、 MEI Quanxi、 LI Hanhong、 WU Zongbin、 QIU Lüqin2026-3
-
Clinical Application Analysis of Domestic Programmed Death-1 Inhibitors in a Hospital: Perspective Based on Health Insurance Policy and Clinical Guidelines
New
Author：NIU Jianhui、 XU Shanshan、 WANG Jiawei2026-3
-
Meta-Analysis on Clinical Efficacy and Safety of Almonertinib in the Treatment of Advanced Non-Small Cell Lung Cancer
New
Author：DING Qinyan、 LI Ruonan、 JIANG Jiakang2026-3
-
Comprehensive Evaluation on Proprotein Convertase Subtilisin / Kexin Type 9 Inhibitors Based on A Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions(the Second Edition)
New
Author：ZHANG Mengting、 WEI Ning、 QI Chao、 LIU Ruohan、 ZHANG Mengzhu、 ZHANG Bei、 MU Shengjun、 SUN Fudong2026-3
-
Cost-Effectiveness Comparison of Three Glycyrrhizic Acid Preparations in the Treatment of Anti-Tuberculosis Drug Induced Liver Injury
New
Author：PU Jialin、 YANG Jinyan、 TU Kangwan、 PAN Xiaojun、 CAI Haifeng2026-3
-
Quantitative Evaluation on Drug Selection of Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor in the Treatment of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer
New
Author：YANG Xiaoyuan、 CHU Mingjuan、 LIU Keqin、 SHEN Zhichuan、 TANG Jianhua2026-3